Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in PEPG — PepGen Inc.

CIK 1595888 NEW YORK, NY
Back to PEPG Full portfolio

Position in PEPG

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$310,341
-$39,040 QoQ
Shares Held
172,412
-12.7% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 72 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PEPG Over Time

Shares Held

Position Value (USD)

Derivatives in PEPG

reported options exposure · as of Mar 31, 2026
CallValue
$25,665
CallShares
14,500
PutValue
$82,836
PutShares
46,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. PEPG ranks #149 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in PEPG

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $310,341 172,412
2026-03-31 $25,665 14,500
2026-03-31 $82,836 46,800
2026-03-31 $349,381 197,391
2025-12-31 $1,254,690 192,733
2025-09-30 $5,046,888 1,092,400
2024-09-30 $237,245 27,748
2024-06-30 $343,044 21,494
2023-12-31 $76,350 11,228
2023-06-30 $135,029 15,104